Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. signed an agreement to acquire Shapuaisi Qiangshen Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) for CNY 82 million on April 9, 2021. Under the terms, Jilin Yueshi Tianbo Pharmaceutical won a bid to acquire and has paid a deposit CNY 10 million. Within 30 working days after the contract becomes effective, Jilin Yueshi Tianbo Pharmaceutical must pay 51% of the transfer price and Within 20 working days from the transfer completion date, Jilin Yueshi Tianbo Pharmaceutical must pay the remaining amount. The balance sheet items of Shapuaisi Qiangshen Pharmaceutical as of August 31, 2020, are total assets of CNY 253.22 million and net assets of CNY 168.73 million. The transaction is subject to approval of shareholder and approved by the Board of Directors of Zhejiang Shapuaisi Pharmaceutical.